Support for Upfront Immunotherapy in Advanced Renal Cell Cancer – Medscape
Medscape |
Support for Upfront Immunotherapy in Advanced Renal Cell Cancer
Medscape Support for Upfront Immunotherapy in Advanced Renal Cell Cancer. Megan Brooks. February 05, 2018. In a phase 3 study of patients with previously untreated metastatic renal cell cancer (mRCC), use of the anti-PD-L1 immune checkpoint inhibitor … |
